Pfizer’s vaccine is safe for the 12 to 15 age group, according to the European Medicines Agency when it approved the use of the drug in Europe for children.
It took several weeks to evaluate the effectiveness and safety of the vaccine. We used observation data on 2 thousand children aged 12-15 years who did not have any signs of infection at the time of vaccination. The decision to start vaccination of adolescents will be taken independently by each European state.
Pfizer’s vaccine for children is the same as for adults – two injections spaced 3 weeks apart. Studies show that the immune response in adolescents, that is, the level of antibodies against SARS-CoV-2, is similar to that obtained in the 16-25 age group.
Potential side effects in children are no different from those seen after vaccinations in people aged 16+. It can be mild soreness at the injection site, chills, headache, fatigue, fever. After a few hours or days, they pass without a trace.